Pregled bibliografske jedinice broj: 795708
Intravenous dexamethasone in acute management of vestibular neuritis : a randomized, placebo- controlled, single-blind trial
Intravenous dexamethasone in acute management of vestibular neuritis : a randomized, placebo- controlled, single-blind trial // European journal of emergency medicine, 23 (2016), 5; 363-369 doi:10.1097/MEJ.0000000000000275 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 795708 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Intravenous dexamethasone in acute management of vestibular neuritis : a randomized, placebo- controlled, single-blind trial
Autori
Adamec, Ivan ; Krbot Skorić, Magdalena ; Gabelić, Tereza ; Barun, Barbara ; Ljevak, Josip ; Bujan Kovač, Andreja ; Jurjević, Ivana ; Habek, Mario
Izvornik
European journal of emergency medicine (0969-9546) 23
(2016), 5;
363-369
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
vestibular neuritis; emergency department; intravenous dexamethasone
Sažetak
The aim of the present study was to evaluate the role of intravenous dexamethasone in relieving the symptoms and signs of vestibular neuritis in the emergency department setting. This was a randomized, placebo-controlled, superiority, single-blind study. Patients were randomized either to intravenous dexamethasone (group A) or to placebo (group B), with all patients receiving symptomatic therapy. The primary outcome was defined as necessity to hospitalize patients who present with vestibular neuritis in the emergency department. The secondary outcomes were (a) improvement in nystagmus, (b) improvement in postural instability, (c) lessening of nausea, (d) lessening of vomiting, and (e) recovery of subjective symptoms. Altogether, 100 patients were randomized, 51 into group A and 49 into group B. There was no difference in the hospitalization rate between groups (P=0.284). In both groups, there was a statistically significant difference in the values of all measured variables 2 h after therapy intervention compared with the baseline values. In group A, significantly fewer patients had third- degree nystagmus 2 h after therapy intervention whereas the difference in group B did not reach statistical significance. After therapy, more patients had first-degree nystagmus in group A as well as in group B than before the intervention. There was a significantly greater absolute difference in European Evaluation of Vertigo scale results in group A compared with group B. The value of dexamethasone cannot be established, given the small sample and limitations of the present study. Some observations consistent with clinical improvement cannot exclude a true treatment effect, and further study is still warranted.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ UIP-11-2013-2622
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
MAGDALENA KRBOT SKORIĆ
(autor)
Tereza Gabelić
(autor)
Ivana Jurjević
(autor)
Mario Habek
(autor)
Andreja Bujan Kovač
(autor)
Barbara Barun
(autor)
Ivan Adamec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE